The EPAA aims to replace animal testing by innovative, non-animal testing methods, to reduce the number of animals used and to refine procedures where no alternatives exist or are not sufficient to ensure the safety of substances (the '3R principle'). The partners are pooling knowledge and resources to accelerate the development, validation and acceptance of alternative approaches at national, European and global levels.
The EPAA seeks to bridge the knowledge gap and to facilitate coordination and cooperation via its partners and project platform. It promotes the results via its various European and international activities and events, its annual conference and via its awards and grants that are particularly addressed to young scientists.
Watch the video on the EPAA
EPAA is on Twitter and LinkedIn
"The current coronavirus crisis has affected all of us, in one way or another, with teleworking becoming the rule and most physical meetings and events being cancelled. This also affects some of our work in the EPAA, notably our planned session at the 11th World Congress on Alternatives in Maastricht (WC 11), which has now been postponed to next year. Similarly, the other events for which we have earmarked the 2020 EPAA student grants have been either cancelled or postponed. We will therefore not spend these grants this year but keep the funds for next year’s events. Also, the EPAA session and training at the WC 11 will go ahead next year as planned.
The current crisis has also triggered an unparalleled global research effort on diagnostics, treatments and vaccines for COVID-19, and many of our colleagues, members and their scientists are involved in this. Institutions, not least the EU and its Member States, are providing massive funding through fast-track procedures in order to enable research teams to get started and avoid bureaucratic obstacles as far as possible. Innovative, non-animal methods are part and parcel of these enormous research efforts, and so is enhanced international cooperation amongst teams and institutes. The EPAA welcomes and encourages all these efforts and will continue to contribute to implementing the 3Rs principle in all relevant areas."
Franz Lamplmair (European Commission) and Rob Roggeband (P&G), co-chairs of the EPAA
Launched in November 2005 with the support of European Commissioners Verheugen and Potocnik, the EPAA began operations in 2006. It completed a first mandate of 5 years by the end of 2010.
Due to the encouraging results of the EPAA's projects, the mandate has been renewed for 5-year terms since. Priorities of the second mandate included integrated testing strategies (lead theme 2011), and international collaboration on 3Rs (lead theme 2012-2013).
The new action programme 2021-2025 (92 kB) focuses on facilitating regulatory acceptance.
The vision of EPAA is the replacement, reduction and refinement (3Rs) of animal use for meeting regulatory requirements through better and more predictive science.
The EPAA vision and mission paper (340 kB)
We value your privacy. See the EPAA privacy statement on the protection of your personal data.
Disclaimer: This webpage contains information on past events, such as agendas of annual meetings or workshops, which may contain the names of speakers. If your name is mentioned and you would like us to remove it, please contact GROW-EPAA@ec.europa.eu.